Clinical Trial Update: Valsalva SBP Drop and LVOT Obstruction

View source ↗

Summary

This clinical trial update notes a Valsalva-induced drop in systolic blood pressure and left ventricular outflow tract obstruction in hypertrophic cardiomyopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: HCM, oHCM | Status: RECRUITING